Pharmaceutical & Healthcare Annual Deals Analysis 2012 (Table of Contents)

Pharmaceutical & Healthcare Annual Deals Analysis 2012


February 29, 2012
119 Pages - SKU: GBDT3806262
License type:
Online Download      US $3,500.00
Global Site License      US $10,500.00
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceutical & Healthcare, Global, Deals Summary
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2011
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2011 by Quarter
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals and Deal Values, 2011
2.3 Pharmaceuticals & Healthcare, Global, Top Deals, 2011
2.4 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2011
2.4.1 Medco Health Receives Shareholders’ Approval For Its Acquisition By Express Scripts
2.4.2 Takeda Pharmaceutical Completes Acquisition Of Nycomed International For $13.7 Billion
2.4.3 Gilead Sciences Completes Acquisition Of Pharmasset For $11.2 Billion
2.4.4 Sanofi Completes Public Offering Of Notes For $7 Billion
2.4.5 Teva Completes Acquisition Of Cephalon For $6.8 Billion
2.4.6 DuPont Completes Acquisition Of Danisco
2.4.7 Amgen Completes Public Offering Of Senior Notes For $6 Billion
2.4.8 HCA Completes Public Offering Of Senior Secured Notes For $5 Billion
2.4.9 Teva Pharmaceutical Completes Public Offering Of Senior Notes For $5 Billion
2.4.10 Johnson & Johnson Completes Public Offering Of Notes For $4.4 Billion
3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2011
4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type
4.1 Pharmaceuticals & Healthcare, Global, M&A, 2011
4.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2011 by Quarter
4.1.2 Top M&A Deals in 2011
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2011
4.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2011
4.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2011 by Quarter
4.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2011
4.2.3 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2011
4.2.4 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2011
4.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2011
4.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2011
4.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2011 by Quarter
4.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2011
4.3.3 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2011
4.3.4 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2011
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2011
4.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2011 by Quarter
4.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2011
4.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2011
4.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
4.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals and Deal Value (US$ m), 2011
4.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2011
4.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2011 by Quarter
4.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2011
4.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2011
4.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
4.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, Number Of Deals and Deal Value (US$ m), 2011
4.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
4.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2011
4.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2011 by Quarter
4.6.2 Top Private Equity Deals in 2011
4.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2011
4.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2011
4.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2011 by Quarter
4.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2011
4.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2011
4.7.4 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year
4.7.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2011
4.7.6 Top Venture Financing Deals in 2011
5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2011
5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2011 by Quarter
5.1.2 Oncology - Deals of the Year
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2011
5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2011 by Quarter
5.2.2 Central Nervous System - Deals of the Year
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2011
5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2011 by Quarter
5.3.2 Infectious Disease - Deals of the Year
5.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2011
5.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2011 by Quarter
5.4.2 Immunology - Deals of the Year
5.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2011
5.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2011 by Quarter
5.5.2 Cardiovascular - Deals of the Year
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2011
5.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2011 by Quarter
5.6.2 Metabolic Disorders - Deals of the Year
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2011
5.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2011 by Quarter
5.7.2 Gastrointestinal - Deals of the Year
6 Pharmaceuticals & Healthcare, Deal Summary, By Geography
6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2011
6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2011 by Quarter
6.1.2 North America – Deals of the Year
6.2 Pharmaceuticals & Healthcare, European Region Deals, 2011
6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2011 by Quarter
6.2.2 Europe – Deals of the Year
6.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2011
6.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2011 by Quarter
6.3.2 Asia-Pacific – Deals of the Year
6.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2011
6.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2011 by Quarter
6.4.2 Rest of the World – Deals of the Year
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2011
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2011
8 Further Information
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclosure information
8.5 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2011
Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2011
Table 5: Pharmaceuticals & Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$ m), 2011
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 7: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 8: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2011
Table 9: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
Table 10: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 11: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 12: Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 13 Pharmaceuticals & Healthcare, Global, Top IPOs, 2011
Table 14: Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 15: Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2011
Table 16: Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 17: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2011
Table 18: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
Table 19: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 20: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 21: Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 22: Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2011
Table 23: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 24: Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2011
Table 25: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2011
Table 26: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 27: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2011–Q4 2011
Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Table 29: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Table 31: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2011
Table 32: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2011
Table 33: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Table 34: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2011
Table 35: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2011
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 37: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011–Q4 2011
Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Table 39: Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2011
Table 40: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2011
Table 41: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, 2011
Table 42: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
Table 43: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Table 44: Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2011
Table 45: Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2011
Table 46: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 47: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 48: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2011
Table 49: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
Table 50: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 51: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 52: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2011
Table 53: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2011
Table 54: Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2011
Table 55: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2011
Table 56: Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2011
Table 57: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 58: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 59: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 60: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 61: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 62: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 63: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 64: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 65: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 66: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 67: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 68: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 69: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Table 70: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Table 71: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 72: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Table 73: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 74: Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
Table 75: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 76: Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
Table 77: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2007 - 2011
Table 78: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Table 79: Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2011
Table 80: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2011
1.2 List of Figures
Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2007- 2011
Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
Figure 3: Pharmaceuticals & Healthcare, Global, Number Of Deals (%) and Deal Values (%), 2011
Figure 4 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 5 Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 6: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 9: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 10: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 11: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 12: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Figure 13: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 14: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 15: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 16: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 17: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Figure 18: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2011
Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2011
Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2011
Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2011
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2011
Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2011
Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2011
Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, 2011
Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2011
Figure 33: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 34: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 35: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
Figure 36: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 37: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 38: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%) and Deal Values (%), 2011
Figure 39: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2011
Figure 40: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2011
Figure 41: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 42: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 43: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2011, 2007 - 2011
Figure 44: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 45: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 46: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2011-Q4 2011
Figure 47: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 48: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 49: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 50: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 51: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 52: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 53: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2007 - 2011
Figure 54: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2011-Q4 2011
Figure 55: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 56: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Figure 57: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 58: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Figure 59: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 60: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Figure 61: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2007 - 2011
Figure 62: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2011–Q4 2011
Figure 63: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2011
Figure 64: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2011